Brief: Aptose Announces FDA Allowance Of IND For Phase 1A/B Study Of Cg-806 In Acute Myeloid Leukemia

Aptose Biosciences

29/06/2020 13:01

June 29 (Reuters) - Aptose Biosciences Inc  APS.TO :
    * APTOSE ANNOUNCES FDA ALLOWANCE OF IND FOR PHASE 1A/B STUDY
OF
CG-806 IN ACUTE MYELOID LEUKEMIA
    * APTOSE BIOSCIENCES INC - INTENDS TO INITIATE PHASE 1 A/B
STUDY
OF CG-806 IN SECOND HALF OF 2020

Source text for Eikon:  ID:nGNX3lf8N4 
Further company coverage:  APS.TO 

 ((Briefs@thomsonreuters.com;))